Advertisement

Reactions Weekly

, Volume 1695, Issue 1, pp 102–102 | Cite as

Chlorambucil/obinutuzumab

Severe and prolong haematologic toxicity: case report
Case report
  • 29 Downloads

Reference

  1. Fogliatto L, et al. Obinutuzumab for CLL relapsed and refractory patients when new oral drugs an not available. Blood 130: 2017. Available from: URL: http://www.bloodjournal.org/content/130/Suppl_1/5341?sso-checked=true [abstract] - Brazil

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Personalised recommendations